9556 Background: Tumor formation requires altered motility of transforming cells to invade surrounding tissues. This altered cellular motility involves formation of lamellipodia, protrusions of the plasma membrane at the leading edge of the cell. Recent studies establish a role for phosphatidylinositol-3-kinase (PI3K) and the PI3K/Akt pathway in initiation of membrane ruffling and actin stress fiber formation, events necessary for lamellipodia formation. PI3K regulates the membrane phospholipids PI(4,5)P2 and PI(3,4,5)P3 that serve pivotal roles in cell signaling, and when deregulated, contribute to tumor formation. Methods: We investigated the mechanism of action of TM-601, a synthetic peptide derivative of scorpion venom, in human cancer cells. Multiple established human cancer cell lines were used in these studies, including solid tumor (glioblastoma, prostate, breast, lung, melanoma, colon) and hematologic tumor cell lines (lymphoma, leukemia, myeloma). Histochemical staining, FACS analysis, and in vitro binding assays were used to characterize TM-601 binding, identify specific intracellular targets, and investigate downstream effects. Results: TM-601 bound all cancer cell lines tested and histological staining localized binding to the lamellipodia of cancer cells. Using in vitro binding assays, we identified phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), as the cellular target of TM-601. Additionally, our results indicated multiple downstream consequences of TM-601 binding to PI(4,5)P2, including reduced activity of PI3Kγ, increased activity of GSK3β, and inhibition of DNA synthesis. Conclusions: TM-601 is a novel 36 amino-acid peptide that targets human cancer cells via a phosphatidylinositol phosphate resulting in altered activity of the PI3K/Akt signal transduction pathway. 131I-TM-601 is currently in Phase II clinical development for the treatment of adult recurrent glioma. Author Disclosure Employment or Leadership Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration TransMolecular
Read full abstract